アカデミック小児初等医療における患者へのアクセスを促進しながら継続性を高めること
Mary Carol Burkhardt1, Dominick DeBlasio2, William B Brinkman1
1Division of General and Community Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
Academic pediatrics
|February 13, 2026
まとめ
小児 (12-24ヶ月) の小児のケア継続性の向上は,品質改善プロジェクトを通じて達成されました. このイニシアチブは,継続率を向上させ,優れた患者アクセスと家族の好みを尊重しながら,継続率を向上させることに成功した.
科学分野:
- 小児のプライマリーケア
- 品質改善科学とは
- ヘルスケア・デリバリーシステム
背景:
- 医療の継続性は,高品質の小児保健医療に不可欠です.
- 小児 (12-24ヶ月) の継続性の低い割合は,学問的な環境で課題となっています.
- 既存のシステムは,患者のアクセスや好みとの連続性のバランスをとるのに苦労することが多い.
研究 の 目的:
- 学術的な小児初等保健施設での幼い子供 (12-24ヶ月) の介護の継続性を高めること.
- 2年間で継続率を0.32から0.40に上昇させる.
- 患者への例外的なアクセスを維持し,介入全体を通して患者の好みを優先します.
主な方法:
- 大規模な学術小児科医院で品質改善 (QI) プロジェクトが実施されました.
- 介入には,親のインタビュー,柔軟なスケジューリングウィンドウ,患者の好みを求めるなどが含まれていた.
- プロバイダーのテンプレートは,さらに前もって開かれ,解約前に予約が予定されていました.
主要な成果:
- 主なアウトカムである12〜24ヶ月の健康診断の継続性は,0.32から0.42.2に改善した.
- 継続性がない子どもの割合は71%から54%に減少した.
- プロセスの測定では,処分ノート (62%から88%) と予定された将来の任命 (31%から61%まで) の増加を示しました.
結論:
- 品質改善の方法は,若い患者の健康な子供の訪問継続性を効果的に増加させました.
- プロジェクトでは,患者のアクセス率が高く,家族の好みを優先させることに成功しました.
- この研究は,小児初等医療の継続性を高めるための再現可能なモデルを示しています.
関連する概念動画
01:25Continuing Care
2.0K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.0K
01:13Patient-centered Care
3.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
279
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
251
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
251
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
316
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
316